Article info
Review
In the idiopathic inflammatory myopathies (IIM), do reactive oxygen species (ROS) contribute to muscle weakness?
- Correspondence to Professor Robert G Cooper, Department of Musculoskeletal Biology, Faculty of Health & Life Sciences, Institute of Ageing and Chronic Disease, University of Liverpool, 5th Floor, UCD Building, Daulby Street, Liverpool, L69 3GA, UK; rcooper2{at}liverpool.ac.uk
Citation
In the idiopathic inflammatory myopathies (IIM), do reactive oxygen species (ROS) contribute to muscle weakness?
Publication history
- Received December 17, 2014
- Revised March 16, 2015
- Accepted April 5, 2015
- First published April 28, 2015.
Online issue publication
October 31, 2019
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions